As HIV morbidity and mortality continue to decrease due to antiretroviral therapy (ART), attention has turned to age-related comorbidities.1 The number of years that a person with HIV is free from comorbidities is lower than seen in those without HIV.2 For instance, ART has been associated with severe glucose and lipid metabolic abnormalities, and metabolic effects have become an essential clinical issue in people living with HIV.3,4 With the